FOXJ1 and neoplasm: We utilized patient tumor tissue microarrays (TMAs), immunohistochemistry (IHC) for ciliated cell marker-positive (FOXJ1 and/or CAPS) cells, multiplex immunofluorescence (mIF) for ciliated cell marker-positive (CAPS, TUBB4) cells and secretory cell marker (PAX8), and mRNA expression profiles to characterize the distribution of ciliated and secretory cell markers in normal fallopian tubes and endometria, benign and borderline ovarian tumors, and various histologic subtypes and grades of EOC.